Cross-tolerance of dopamine metabolism to baclofen, γ-butyrolactone and HA-966 in the striatum and olfactory tubercle of the rat
- 1 March 1981
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 28 (9) , 973-981
- https://doi.org/10.1016/0024-3205(81)90742-6
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- HA-966 effects on striatal dopamine metabolism: implications for dopamine compartmentalizationJournal of Pharmacy and Pharmacology, 1980
- Differential effects of acute and subacute HA-966 treatment on storage and release of striatal dopamineEuropean Journal of Pharmacology, 1979
- Hypersensitivity of the climbing behaviour response to apomorphine induced by a short depression of dopaminergic neurone activityNeuropharmacology, 1979
- Chronic haloperidol causes persistent increase in 3,4-dihydroxyphenylacetic acid (DOPAC) concentration in the substantia nigra but not in the ventral tegmental areaBrain Research, 1979
- Further studies on the sequence of dopamine metabolism in the rat brainEuropean Journal of Pharmacology, 1979
- Modulation of receptor mechanisms in the CNS: Hyper-and hyposensitivity to catecholaminesNeuropharmacology, 1978
- Differential regional development of tolerance to increase in dopamine turnover upon repeated neuroleptic administrationEuropean Journal of Pharmacology, 1977
- The action of Baclofen on neurons of the substantia nigra and of the ventral tegmental areaBrain Research, 1977
- Increase in mouse brain dopamine content by baclofen: Effects of apomorphine and neurolepticsPsychopharmacology, 1977
- Evidence for a receptor-mediated feedback control of striatal tyrosine hydroxylase activityJournal of Pharmacy and Pharmacology, 1972